CannabisNewsWire
Editorial Coverage: COVID-19 devastated the economy but created
a surge in cannabis sales, bolstering long-term trends.
As the pandemic wreaked havoc on the U.S. and global economies,
cannabis sales rocketed higher across multiple markets in North
America. California cannabis sales
soared nearly 160% compared to the same day in March 2019,
while sales in Washington climbed 100% and Colorado saw a 46%
increase on the same day. This surge gives no indications as a one
off and is strong reinforcement of long-term trends in the
industry. After a lot of early hype, the cannabis sector is on firm
ground and is posting impressive numbers. A strong performer in the
sector, Cannabis Strategic Ventures (OTCQB: NUGS)
(NUGS Profile), is now on pace
for over $2.7 million in quarterly sales and approximately $11
million in annualized sales, based on its strong performance in
April and May. Simultaneously, the company increased its harvest
size by as much as 2.5x and is now selling product at an 11%
premium to industry standard. Powerful new deals confirm sector
viability and vitality. Village Farms
International Inc. (NASDAQ: VFF), one of North
America’s largest vertically integrated greenhouse
growers, recently launched a majority-owned joint
venture for a large-scale, low-cost, high-quality cannabis
production. HEXO Corp.
(NYSE: HEXO), an established consumer packaged
goods cannabis company, just closed a public offering for total
gross proceeds of C$57,546,000. Amyris Inc.
(NASDAQ: AMRS), a global science and technology
leader of pure, sustainable ingredients for consumer products, just
announced a major breakthrough in CBD delivery, improving efficacy
of CBD by 10-40X as the carrier oil chassis for the skin care
market. Tilray Inc.
(NASDAQ: TLRY) a global leader in cannabis
research, cultivation, processing, and distribution announced a
C$90.4 million registered offering. The surge in cannabis sales
during lockdown only adds to a sector that is thriving.
Click here to view the
custom infographic of the Cannabis Strategic Ventures
(OTCQB: NUGS) editorial.
Pandemic’s Unexpected Windfalls
COVID-19 has had a crippling effect on many industries. Shops
and restaurants forced to close, manufacturers unable to operate
their plants, companies across the manufacturing and service
sectors seeing demand plummet. The layoffs and losses are very
real, and no one knows yet what the long-term economic impact will
be.
But some businesses actually benefited from the economic
disruption the pandemic has wrought. There are obvious ones like
pharmaceutical companies and those producing protective equipment
for medical staff. There are the tech businesses that facilitate
working from home, providing software for virtual workspaces and
online meetings. And there has been a huge increased demand for
home entertainment, which has spilled over into a less obvious
sector – cannabis producers such as Cannabis Strategic
Ventures (OTCQB: NUGS) (NUGS
Profile).
COVID Lends Cannabis a Lift
Cannabis was already a boom industry in North America. This has
been driven by a range of recent changes, such as recreational
legalization in Canada, federal legalization of hemp in the US, and
the repeal of prohibition across a growing number of states. This
has allowed the growth of companies such as Cannabis Strategic
Ventures, which cater to a growing market as customers move from
criminal supply channels to legal ones.
Demand exploded during the early stages of COVID-19’s spread
through North America. According to the
Bank of America Securities, there were record sales of cannabis
as consumers stockpiled, preparing for a lockdown. While some
people bought mountains of toilet paper or tinned food, both
medical and recreational cannabis users were making sure they had
enough to see them through a crisis.
The result was a spike in sales in April and May, to the benefit
of companies with recognizable quality brands such as Cannabis
Strategic Ventures. Sales could have been stymied as states locked
down and restricted business to control the spread of COVID-19. But
most states
classified cannabis as an essential product, allowing sales to
continue even as other parts of the economy were shutting down.
Together, these factors led to record sales for some cannabis
companies, with Cannabis Strategic Ventures celebrating increased
sales of
cannabis product from its core cultivation facility and adding
staff to address the rising demand.
Strong Contender Seizes Market Opportunity
These sales marked an extraordinary month for NUGS. Despite
restrictions on business due to COVID-19, the company had
record-breaking sales in the final week of April, putting monthly
sales 800% higher than
the monthly average for Q1.
Any fears that this might be a blip caused by panic buying at
the start of the pandemic vanished the following month, when the
company announced sales from its most recent harvest. With cannabis
sales in the US average roughly $1,525 per pound, the company
sold its product
at around $1,700 per pound, 11% above benchmark levels. This
was a particularly impressive price given that it had been selling
at a discount relative to the benchmark only six months before.
Of course, not all cannabis companies will benefit from the
crisis. Their ability to profit depends in large part on the
strength of their existing business. NUGS had been building up its
business prior to the crisis, with the addition of a
six-acre cultivation site in 2019, capable of four or five
harvests per year.
Seizing the market opportunity brought by COVID-19, the company
has announced further improvements in the first half of 2020.
Work on both the
quantity and the quality of output has more than doubled the
output of cultivation facilities while supporting rising prices for
its products.
Cannabis Industry Evolves
The long-term expansion of legal markets has led to dramatic
growth for cannabis companies over the past decade, and the
COVID-19-related influx of revenues provides well-run businesses
the resources they need for further expansion. Late April and early
May saw Cannabis Strategic Ventures sell out its
entire stock every week for a month.
“We have never seen anything like this,” said Cannabis Strategic
Ventures CEO Simon Yu. “We booked $100,000 in one day to clear out
all of our remaining inventory. We anticipated this dynamic but
still underestimated the force of the trend. Too much demand is
always the problem you want to have.”
NUGS sold $929,000 of
cannabis products in May and expects to see even greater sales
in June. Expanded inventory and product range have supported this
growth even in a time of crisis, while reinvestment from that
growth will let the company further expand its capacity.
Part of the sector’s success comes from producing a varied range
of brands and products. Rather than just selling weed, the more
successful companies have been developing a variety of cannabis
derivatives for different markets. While the recent boom in sales
has come from demand for cannabis itself, related brands have
diverse interests in supporting long-term growth of the market,
normalizing cannabis and its derivatives as consumer products, and
protecting companies against a disruption in any individual part of
the market.
Cannabis Players Execute on Varied
Strategies
The boom in sales brought about by the COVID-19 crisis has
created an opportunity for a range of growing companies.
Village Farms International Inc. (NASDAQ: VFF)
is one of the largest and longest-operating vertically integrated
greenhouse growers in North America. The company announced that its
majority-owned joint venture for large-scale, low-cost,
high-quality cannabis production, Pure Sunfarms, has received from
Health Canada its cannabis cultivation sales license based on an
initial production area within its second 1.1 million square foot
greenhouse facility in Delta, British Columbia.
HEXO Corp. (NYSE: HEXO) is an award-winning
consumer packaged goods cannabis company that creates and
distributes innovative products to serve the global cannabis
market. The company serves the Canadian adult-use markets under its
HEXO Cannabis and Up Cannabis brands, and the medical market under
HEXO medical cannabis. The company recently closed a public
offering for total gross proceeds to the company of
C$57,546,000.
Amyris Inc. (NASDAQ: AMRS) is a global science
and technology leader of pure, sustainable ingredients for the
Health & Wellness, Clean Beauty and Flavors & Fragrances
markets. The company recently presented clinical data showcasing
the superiority of its natural sugarcane squalane (marketed and
sold as Neossance Squalane) as a carrier of CBD versus other oils.
In order for CBD to be effective in topical applications, skin
penetration is a key factor. Amyris sugarcane squalane improves the
efficacy of CBD by 10-40X as the carrier oil chassis for the skin
care market based on new data.
Tilray Inc. (NASDAQ: TLRY) is a global leader
in cannabis research, cultivation, processing and distribution. An
industry pioneer, Tilray was the first GMP-certified medical
cannabis producer to supply cannabis flower and extract products to
tens of thousands of patients, physicians, pharmacies, hospitals,
governments, and researchers on five continents.
COVID-19 devastated the global economy but spurred a revenue
spike in the cannabis industry, substantiating the opportunity in
an already rapidly expanding sector.
For more information on Cannabis Strategic Ventures, please
visit Cannabis
Strategic Ventures (OTCQB: NUGS)
About CannabisNewsWire
CannabisNewsWire (CNW) is an information service that provides
(1) access to our news aggregation and syndication servers, (2)
CannabisNewsBreaks that summarize corporate news and
information, (3) enhanced press release services, (4) social media
distribution and optimization services, and (5) a full array of
corporate communication solutions. As a multifaceted financial news
and content distribution company with an extensive team of
contributing journalists and writers, CNW is uniquely positioned to
best serve private and public companies that desire to reach a wide
audience of investors, consumers, journalists and the general
public. CNW has an ever-growing distribution network of more than
5,000 key syndication outlets across the country. By cutting
through the overload of information in today’s market, CNW brings
its clients unparalleled visibility, recognition and brand
awareness. CNW is where news, content and information converge.
To receive instant SMS alerts, text CANNABIS to 21000 (U.S.
Mobile Phones Only)
For more information please visit https://www.CannabisNewsWire.com
Please see full terms of use and disclaimers on the
CannabisNewsWire website applicable to all content provided by CNW,
wherever published or re-published: http://CNW.fm/Disclaimer
Do you have questions or are you interested in working with CNW?
Ask our
Editor
CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com
CannabisNewsWire is part of the InvestorBrandNetwork.
DISCLAIMER: CannabisNewsWire (CNW) is the source of the Article
and content set forth above. References to any issuer other than
the profiled issuer are intended solely to identify industry
participants and do not constitute an endorsement of any issuer and
do not constitute a comparison to the profiled issuer. The
commentary, views and opinions expressed in this release by CNW are
solely those of CNW. Readers of this Article and content agree that
they cannot and will not seek to hold liable CNW for any investment
decisions by their readers or subscribers. CNW is a news
dissemination and financial marketing solutions provider and is NOT
registered broker-dealers/analysts/investment advisers, hold no
investment licenses and may NOT sell, offer to sell or offer to buy
any security.
The Article and content related to the profiled company
represent the personal and subjective views of the Author, and are
subject to change at any time without notice. The information
provided in the Article and the content has been obtained from
sources which the Author believes to be reliable. However, the
Author has not independently verified or otherwise investigated all
such information. None of the Author, CNW, or any of their
respective affiliates, guarantee the accuracy or completeness of
any such information. This Article and content are not, and should
not be regarded as investment advice or as a recommendation
regarding any particular security or course of action; readers are
strongly urged to speak with their own investment advisor and
review all of the profiled issuer’s filings made with the
Securities and Exchange Commission before making any investment
decisions and should understand the risks associated with an
investment in the profiled issuer’s securities, including, but not
limited to, the complete loss of your investment.
CNW HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.
This release contains “forward-looking statements” within the
meaning of Section 27A of the Securities Act of 1933, as amended,
and Section 21E the Securities Exchange Act of 1934, as amended and
such forward-looking statements are made pursuant to the safe
harbor provisions of the Private Securities Litigation Reform Act
of 1995. “Forward-looking statements” describe future expectations,
plans, results, or strategies and are generally preceded by words
such as “may”, “future”, “plan” or “planned”, “will” or “should”,
“expected,” “anticipates”, “draft”, “eventually” or “projected”.
You are cautioned that such statements are subject to a multitude
of risks and uncertainties that could cause future circumstances,
events, or results to differ materially from those projected in the
forward-looking statements, including the risks that actual results
may differ materially from those projected in the forward-looking
statements as a result of various factors, and other risks
identified in a company’s annual report on Form 10-K or 10-KSB and
other filings made by such company with the Securities and Exchange
Commission. You should consider these factors in evaluating the
forward-looking statements included herein, and not place undue
reliance on such statements. The forward-looking statements in this
release are made as of the date hereof and CNW undertakes no
obligation to update such statements.
Source:
CannabisNewsWire
Contact:
CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
212.418.1217 Office
Editor@CannabisNewsWire.com
Cannabis Strategic Ventu... (CE) (USOTC:NUGS)
과거 데이터 주식 차트
부터 12월(12) 2024 으로 1월(1) 2025
Cannabis Strategic Ventu... (CE) (USOTC:NUGS)
과거 데이터 주식 차트
부터 1월(1) 2024 으로 1월(1) 2025
